<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00421967</url>
  </required_header>
  <id_info>
    <org_study_id>2006-004638-33.</org_study_id>
    <nct_id>NCT00421967</nct_id>
  </id_info>
  <brief_title>Postoperative Analgesia After Total Knee Arthroplasty</brief_title>
  <official_title>Postoperative Analgesia After Total Knee Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Continuous Intraarticular Infusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total knee arthroplasty (TKA) is associated with moderate to severe postoperative pain.
      Although epidural treatment provides good and reliable postoperative pain relief after THA,
      it may cause urinary retention, nausea, hypotension, diminished muscle control, and delayed
      mobilization.

      The challenge of new analgesic regimes is to reduce the occurrence of side effects while
      maintaining adequate pain relief and maximum muscle control. A relatively new method to
      provide postoperative pain relief after TKA is local infiltration analgesia combined with
      single-shot injection(s) or continuous infusion of local anesthetics into the surgical site.
      As local infiltration analgesia combined with continuous intraarticular infusion compared
      with continuous epidural infusion has not been evaluated, our study was designed to determine
      whether this technique could enhance analgesia and improve patient outcome after TKA. This
      study compares continuous epidural infusion of Ropivacaine and intravenous Ketorolac with
      local infiltration analgesia with Ropivacaine, Ketorolac and Adrenaline combined with
      continuous intraarticular infusion of Ropivacaine and Ketorolac.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim analysis
  </why_stopped>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analg√©sia consumption</measure>
    <time_frame>48 h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to discharge</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokine level</measure>
    <time_frame>48 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores VAS</measure>
    <time_frame>72 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side-effects</measure>
    <time_frame>72 h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine, Ketorolac, adrenaline</intervention_name>
    <description>Infiltration: 150 ml Ropivacaine 2mg/ml added 1 ml Ketorolac 30 mg/ml and 0,5 ml Adrenaline 1 mg/ml Intraarticular infusion: 4 ml/h 384 mg Ropivacaine 60 mg Ketorolac</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Ketorolac</intervention_name>
    <description>Epidural infusion: 4 ml/h 384 mg Ropivacaine I.V. Ketorolac 90 mg</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted consecutively to primary total knee arthroplasty.

          -  Provided informed consent

        Exclusion Criteria:

          -  Fertile women with positive pregnancy test, nursing mothers, fertile women who do not
             use safe contraception

          -  Severe chronic neurogenic pain

          -  Medical treated diabetes

          -  Contraindications for spinal aesthesia and epidural analgesia

          -  Known hypersensitivity towards study drugs

          -  Rheumatoid arthritis

          -  Treatment with narcotics

          -  Treatment with antidepressants

          -  Severe obesity BMI&gt;35

          -  Treatment with antacid

          -  Not able to speak and understand Danish
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgitte V Christensen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup Hospital, Glostrup 2600, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glostrup Hospital</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2007</study_first_submitted>
  <study_first_submitted_qc>January 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2007</study_first_posted>
  <last_update_submitted>May 6, 2008</last_update_submitted>
  <last_update_submitted_qc>May 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Kjeld Soballe</name_title>
    <organization>Aarhus University Hospital</organization>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

